We serve Chemical Name:7-Methoxy-1-indanone CAS:34985-41-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:7-Methoxy-1-indanone
CAS.NO:34985-41-6
Synonyms:2,3-Dihydro-7-methoxy-1H-inden-1-one;7-Methoxy-2,3-dihydro-1H-inden-1-one;7-Methoxy-1-indanone;7-Methoxy-indan-1-on;MFCD07784339;7-Methoxyindan-1-one;1H-Inden-1-one, 2,3-dihydro-7-methoxy-;7-methoxyindanone
Molecular Formula:C10H10O2
Molecular Weight:162.185
HS Code:2914509090
Physical and Chemical Properties:
Melting point:99-102ºC
Boiling point:305.3±31.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.564
PSA:26.30000
Exact Mass:162.068085
LogP:2.32
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 2,3-Dihydro-7-methoxy-1H-inden-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-methoxyindanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Dihydro-7-methoxy-1H-inden-1-one Use and application,7-Methoxy-1-indanone technical grade,usp/ep/jp grade.
Related News: The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 7-Methoxy-1-indanone manufacturer The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 7-Methoxy-1-indanone supplier U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. 7-Methoxy-1-indanone vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. 7-Methoxy-1-indanone factory U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.
